Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,060,747 papers from all fields of science
Search
Sign In
Create Free Account
MVE-2
Known as:
MVE 2
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyran Copolymer
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PENGEMBANGAN MEDIA AUDIO VISUALMATH VIDEO EDUCATION (MVE)PADA PEMBELAJARAN MATEMATIKABAGI ANAK TUNAGRAHITA RINGAN
Berta Lestari
2016
Corpus ID: 187486399
Penelitian ini dilatarbelakangi oleh adanya karakteristik khusus yang dimiliki siswa tunagrahita, sehingga diperlukan media…
Expand
2009
2009
PENGARUH LABA DAN KOMPONEN ARUS KAS TERHADAP NILAI PERUSAHAAN PADA PERUSAHAAN BERTUMBUH DAN TIDAK BERTUMBUH
Aguswan
2009
Corpus ID: 194555611
Penelitian ini bertujuan untuk mendapatkan bukti empiris mengenai pengaruh variabel bebas laba (EAT), arus kas operasi (CFO…
Expand
1986
1986
Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice.
E. Schlick
,
P. Hewetson
,
R. Ruffmann
Cancer Research
1986
Corpus ID: 17122507
Starting from the observation that success of combined treatment of MBL-2 tumor-bearing mice with the alkylating agent…
Expand
1986
1986
Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
Michael A. Chirigos
,
Erich Schlick
,
Tohru Saito
,
E. Gruys
Methods and Findings in Experimental and Clinical…
1986
Corpus ID: 35561147
Pharmacokinetic studies of five biological response modifiers (BRMs) show diverse regulator functions on effector cell responses…
Expand
1985
1985
Therapy of peritoneal murine cancer with biological response modifiers.
Raoul R. Salup
,
Ronald B. Herberman
,
Michael A. Chirigos
,
T. Back
,
R. Wiltrout
Journal of Immunopharmacology
1985
Corpus ID: 25502814
We have used a murine renal adenocarcinoma of spontaneous origin (Renca) inplanted in the peritoneal cavity to study the…
Expand
1985
1985
Modulation of myelopoiesis by CSF or CSF-inducing biological response modifiers.
Erich Schlick
,
Ralf Ruffmann
,
Klaus Hartung
,
Michael A. Chirigos
Journal of Immunopharmacology
1985
Corpus ID: 36881183
We have compared the effects on number and function of bone marrow progenitors and peripheral effector cells of the…
Expand
1984
1984
Immunomodulation and antitumor effects of MVE-2 in mice.
J. Talmadge
,
A. Maluish
,
+4 authors
R. Wiltrout
Journal of Biological Response Modifiers
1984
Corpus ID: 25996940
The biological response modifier maleic anhydride-divinyl ether (MVE-2) can activate natural killer (NK) cells and macrophages…
Expand
1983
1983
Evaluation of the immunological and toxicological properties of MVE-2 in phase I trials.
John J. Rinehart
,
D. Young
,
James A. Neidhart
Cancer Research
1983
Corpus ID: 9034043
Pyran copolymer enhances resistance to infections and transplantable tumors in mice. It induces interferon, activates macrophages…
Expand
1983
1983
Prostaglandin E synthesis and release by murine macrophages and human monocytes after in vitro treatment with biological response modifiers.
Klaus Hartung
,
Erich Schlick
,
H. C. Stevenson
,
Michael A. Chirigos
Journal of Immunopharmacology
1983
Corpus ID: 21527246
Prostaglandins of the E series (PGE), produced by mononuclear phagocytes, have many biological activities and are involved in the…
Expand
1981
1981
Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
Luka Milas
,
E. Hersh
,
Nancy R. Hunter
Cancer Research
1981
Corpus ID: 2826837
A 15,500 molecular-weight fraction of a pyran copolymer, (MVE-2) was investigated for its therapeutic efficacy against artificial…
Expand